Wednesday, April 29, 2020

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump Favipiravir, manufactured under the brand name Avigan by a unit of Japan#39;s Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

from Moneycontrol Business News https://ift.tt/3bQ2Kd5

No comments:

Post a Comment

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...